Pfizer to Raise Drug Prices, Ending Trump-Requested Freeze
This article is for subscribers only.
Pfizer Inc., the U.S.’s biggest drugmaker, will raise prices on about 10 percent of its pharmaceutical products next year after briefly halting such increases at the request of President Donald Trump earlier this year.
The average list-price increase on the 41 drugs will be about 5 percent, Pfizer said in a statement Friday.